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https://doi.org/10.1186/s41927-020-00156-1RESEARCH ARTICLE Open AccessCardiovascular risk knowledge in patients
of South Asian origin living with
rheumatoid arthritis: data from India and
the UK
Kanta Kumar1* , Suvrat Arya2, Peter Nightingale3, Tom Sheeran4 and Amita Aggarwal2Abstract
Background: South Asians have a higher risk of cardiovascular disease (CVD). Rheumatoid arthritis (RA) increases
the risk of premature atherosclerosis. We investigated whether there was a substantial difference in the level of CVD
risk knowledge among patients of South Asian origin with RA in India and in the UK.
Methods: In this cross-sectional survey, patients of South Asian origin with RA from India and the UK were
recruited from secondary care settings. Data were collected via Heart Disease Fact Questionnaire-Rheumatoid
Arthritis (HDFQ-RA), a validated self-completion questionnaire. The HDFQ-RA was translated into Hindi and piloted
among patients from South Asian background before use. Additionally, clinical and demographic data was
collected.
Results: Among 118 patients from each country, 84% were female and they had similar age, education level,
employment status and co-morbidities. Patients from India had longer disease duration (5.5 years versus 4.1 years
(p = 0.012) whereas those from the UK had higher disease activity score (4.0 + 0.8 versus 3.1 + 0.7, p < 0.01).
Regarding modifiable risk factors for CVD only 51.2% from India and 51.3% in the UK were aware of them. However,
awareness of the link between RA and increased risk of CVD was even more limited (32.8% in India and 34.4% in
UK).
Conclusion: Patients of South Asians origin with RA from both countries had limited knowledge about CVD risk.
There is a need to educate them about CVD risk during consultation, as this will result in better outcomes.
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Cardiovascular diseases (CVD) related to atherosclerosis; in-
clude ischaemic heart disease, stroke and peripheral vascular
disease [1]. CVD is the leading causes of death in most of
high-low- and middle-income countries [2]. Low and
middle-income countries account for more than 80% of glo-
bal deaths and 85% of global disability from CVD [2, 3].
CVD risk is known to escalate in certain co-morbid diseases
such as rheumatoid arthritis (RA) [4]. Patients with RA have
increased rates of CVD for reasons that are not fully under-
stood [5]. Contributing factors include persistent inflamma-
tion related to systemic disease activity, use of medications
such as glucocorticoids and possibly the effects of cytokines
[6]. The overall increased risk of CVD in the RA population
exceeds that predicted by increased rates of traditional risk
factors [1].
Globally, it has been noted that controlling comorbidi-
ties such as hypertension and signs of dyslipidaemia very
much fall into the domain of a rheumatologist [1]. As a
result, European League Against Rheumatism (EULAR)
present clear recommendations on managing CVD risk
in RA patients [1]. The consequences of accelerated ath-
erosclerosis include an increased risk of cerebrovascular
and coronary heart disease (CHD) [7]. This is particu-
larly so in South Asian population where the effect of
RA itself on premature CVD appears to be substantial
[8]. In addition, the South Asian population has a base-
line higher prevalence of CVD [9]. In RA, about a third
of patients of South Asian origin with active disease have
higher levels of subclinical atherosclerosis than other RA
population [8]. These data mainly emerge from India
and are limited in other parts of the European countries
where migrated population have settled over time. Pa-
tient knowledge and understanding of CVD risk factors
are largely derived from data obtained in developed
countries [10] and there is a gap in data from patients
with a South Asian background living with RA.
There is wealth of data showing poor outcomes in the
non-RA South Asian population with CVD [9, 11, 12].
Several studies [9, 11, 12] have examined barriers to life-
style change in South Asian populations [13]. Factors
such as language barriers, illness beliefs and lack of cul-
turally appropriate opportunities have been cited [3, 14].
Additionally, a review of health promotion in ethnic mi-
nority groups emphasized understanding differences of
health beliefs [15] and where possible to design cultural
sensitive educational programmes for patients of South
Asian origin in different countries [15].
While interventions exist for the non-RA population
suffering from CVD [16], in rheumatology practice only
one study has attempted to address the needs of patients
regarding CVD risk [17]. In that UK study targeted
White British patients with RA, incorporated cognitive
behavioural change strategies [17]. Moreover, that studysuggested that education regarding CVD to patients with
RA helped them understand that RA is an added risk for
developing CVD [17]. However, patients from ethnic mi-
nority backgrounds were not included in that study. The
current literature in rheumatology highlights the need to
develop our understanding around the CVD risk know-
ledge of patients from South Asian origin living with
RA. This is needed to inform clinical practice and
inform policy makers of the possibility of a cultural sen-
sitive programme in rheumatology targeting high-CVD-
risk groups. Additionally, no study has attempted to
compare patient perceptions from two different coun-
tries. This would help to develop knowledge around
similarities and differences moreover would assist clini-
cians in planning strategies to reduce long-term cardio-
vascular morbidity in RA for patients of South Asian
origin. With this in mind, the aim of this pilot cross sec-
tional survey was to evaluate the level of knowledge of
CVD among patients of South Asian origin with RA. We
collected data from India and the UK to see whether
there was a substantial difference in the level of know-
ledge between the two countries that would be worthy
of further investigation. In addition, we collected data on
patients’ illness perspectives of RA.
Methods
This cross-sectional study was conducted at the Sanjay
Gandhi Institute for Postgraduate Medical Sciences lo-
cated in the North East of India and the Wolverhampton
Royal NHS Trust in the Midlands, UK. Sanjay Gandhi
Institute for Postgraduate Medical Sciences is known as
one of the centre of excellence for rheumatology with an
extensive profile of academic research capturing people
from neighbouring regions. The UK centre also is lo-
cated to capture a large proportion of patients from eth-
nic minority backgrounds. Consecutive patients with RA
were approached during their routine rheumatology ap-
pointments in both settings. In India, patients presented
from different geographic regions around Lucknow. In
the UK, patients presented to New Cross and Cannock
Chase Hospitals as part of Royal Wolverhampton NHS
Trust which takes referrals from across the Midlands. In
India, a member of the research team approached pa-
tients while they were waiting to see their consultant. In
the UK, patients were approached while waiting to see
both consultant or nurse specialist by a member of the
research team. If patients expressed an interest in taking
part, they were given a Patient Information Sheet outlin-
ing the study and time to ask questions before giving
their consent. The study was approved by the ethics
committees of both institutions (Indian Ethics Commit-
tee IEC 2018–65-DM-103- and UK West Midlands Re-
search Ethics Committee 18/WM/0344). Patients were
recruited if they: (1) Self-defined themselves as being of
Kumar et al. BMC Rheumatology            (2020) 4:57 Page 3 of 9South Asian origin and in addition for ‘South Asian’ ori-
gin three or more grandparents born in India for UK
India or Pakistan; (2) Fulfilled classification criteria for
RA [18]. A number of questionnaires were used to col-
lect data from patients. These socio-economic variables
were collected (age, gender, occupation and ethnicity) along
with clinical data including the disease activity score (DAS)
[18]. DAS28 data were extracted from routine follow up
clinics around the time when patients took part in the study
(within 1–2months), knowledge about CVD was collected
by using the Heart Disease Fact Questionnaire-Rheumatoid
Arthritis (HDFQ-RA) [19], a validated self-completion
questionnaire [19]. We used both HDFQ-RA 1 and HDFQ-
RA 2 containing 26 items to provide a more comprehensive
perspective of CVD risk knowledge in patients of South
Asian origin. The Illness perception questionnaire (IPQ)
was available in Hindi [20, 21].
To accommodate non-English speaking patients in
India, HDFQ-RA was translated into Hindi (common
language spoken by patients at Sanjay Gandhi) using
established guidelines [22]. The validated questionnaire
available in English was translated into Hindi by two
established rheumatology health experts (SA & AA).
First, the questionnaire was translated in Hindi by SA
and then corrected by AA for ease of understanding and
was adapted to the local population. The following mod-
ifications were made: (1) question 3; option living with a
partner was removed since this could have appeared to
be offensive for the population in India, (2) question 4;
options were changed to reflect equivalent school and
educational attainments, (3) question 14; many of the
options had to be removed or modified as western
model of care service do not feature in India. For ex-
ample, CVD screening clinic, attendance to nurse spe-
cialist clinic. The translated HDFQ-RA was also read by
a departmental staff member for further independent
validity. The aim of this process was to ensure that pa-
tients understood the questionnaire. After this exercise,
a pilot was conducted with five patients to validate and
to ensure that the questions were easily understood. For
the UK patients, in whom English was not their first lan-
guage a hospital translator was used to assist patients to
complete the HDFQ-RA. The responses given by pa-
tients who filled in the questionnaires themselves and by
patients who completed the Hindi HDFQ-RA were
checked for reliability of the responses by the statistician
(PN). Reliability was adequate for both English (Cron-
bach’s alpha = 0.81 for HDFQ-RA 1 and 0.82 for HDFQ-
RA 2) and non-English versions (0.76 and 0.81).
Statistical analysis
Data were analysed using SPSS Statistics for Windows
Version 22.0 (IBM Corp., Armonk, NY). Categorical data
are summarised as counts and percentages. The t-test,Fisher’s exact test and Kendall’s tau-b were used to com-
pare the demographic and clinical data. As the disease
duration was positively skewed it was log transformed
prior to analysis. Patients’ responses to HDFQ-RA 1 and
HDFQ-RA 2 were presented as percentages. The general
and RA related CVD knowledge scores for each patient
were calculated as the percentages of the relevant
HDFQ-RA 1 and HDFQ-RA 2 questions answered cor-
rectly by each patient. A single general score and a single
RA related score were obtained as the means of these
scores for HDFQ-RA1 and HDFQ-RA 2. Kendall’s tau-b
was used to compare scores between groups. The
Mann-Whitney test and Fisher’s exact test were used to
analyse the illness perception questionnaire data. A sam-
ple size of 118 per group was chosen so that for each
question in the HDFQ-RA a two-sided Fisher’s exact test
had more than 80% power at the 5% significance level to
detect a difference of 20 between the proportions in the
two groups expressed as percentages.
Results
In India, 124 patients were approached for the study. Out
of these six declined to participate, three of them due to
lack of time and the others because of illiteracy. In the
UK, we approached 132 patients of those 14 declined to
complete the questionnaires. The main reasons were lack
of time and commitment after their clinical appointments.
In total 236 patients (118 from each country) were re-
cruited to the study. The majority of the participants were
females (Table 1). In the UK centre, seven participants re-
quired assistance in completing the questionnaires via the
hospital translator. The level of education as well as em-
ployment status was similar in the patients from the two
countries. There were more patients in full time employ-
ment in India than UK although this difference was not
significant. History of co-morbidities such as heart attacks,
angina, diabetes, high blood pressure, high cholesterol,
obesity was similar in two countries. However, there was a
trend towards higher frequency of diabetes (11.9% versus
7.1%), hypertension (28% Vs 25%), and high cholesterol
(16.1% Vs 8.6%) among UK patients. Higher numbers of
the UK patients were taking cholesterol lowering drugs
(p = 0.045) and anti-hypertensives (p = 0.034).
Disease related variables
The disease activity score was higher in the UK patients
than the Indian South Asian patients (4.0 + 0.8 versus
3.1 + 0.7; P < 0.001) reporting more tender joints. The
disease duration was higher in the Indian South Asian
patients (5.5 years versus 4.1 years; P = 0.012).
CVD risk knowledge in general between India and UK
In both countries, patients had poor knowledge of risk
factors associated with CVD with only 51.2% patients in
Table 1 characteristic of patients
Indian UK P value
Number 118 118
Age (years); mean (SD) 44 (12) 45 (12) 0.545a
Female 83.9% 84.7% 1.000b
Highest level of education 0.870c
1. None 11.0% 5.9%
2. GCSE/0 level/10th grade 17.8% 26.3%
3. A-level diploma vocational qualification/12th grade 18.6% 21.2%
4. Degree 20.3% 12.7%
5. post graduate 32.2% 33.9%
Employment 0.971b
Full time 18.6% 16.9%
Part time 5.9% 8.5%
Unemployment 3.4% 2.5%
Not working due to RA 0.8% 0.0%
Retired 5.9% 5.9%
Home maker 61.0% 61.0%
Student 4.2% 5.1%
Age at diagnosis (years); mean (SD) 37 (11) 38 (11) 0.532a
Height (metres); mean (SD) 1.56 (0.08) 1.57 (0.09) 0.445a
Weight (kilograms); mean (SD) 57.9 (10.2) 57.4 (9.6) 0.675a
History of co-morbidities
Heart attack 1.7% 0.8% 0.619b
Angina 1.9% 5.9% 0.179b
Diabetes 7.1% 11.9% 0.265b
High blood pressure 25.0% 28.0% 0.658b
High cholesterol 8.6% 16.1% 0.107b
Obesity 19.5% 13.6% 0.287b
Smoking 2.5% 8.5% 0.083b
Previous smoking status 6.8% 7.6% 1.000b
Family history of CVD 22.9% 20.3% 0.752b
Information on TV or media 36.4% 33.1% 0.682b
CVD and diabetes medications
Cholesterol lowering medications 5.5% 13.6% 0.045b *
Blood pressure lowering medications 14.2% 25.4% 0.034b *
Blood pressure of above patients
Normal 13% 50% 0.017c *
Elevated 6% 0%
Stage 1 44% 43%
Stage 2 25% 7%
Not available 13% 0%
Insulin 4.5% 2.5% 0.490b
Anti-inflammatory drugs 60.6% 53.8% 0.347b
Corticosteroids 35.4% 25.4% 0.134b
Disease-modifying antirheumatic drugs 100% 100% 1.000b
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Table 1 characteristic of patients (Continued)
Indian UK P value
Biological drugs 0% 12.7% < 0.001b *
DAS 28 mean;(SD) 3.1(0.7) 4.0(0.8) < 0.001a *
Disease duration (years); geometric mean 5.5 4.1 0.012a *
* = significant at < 0.05 a = t test (for disease duration data were log transformed), b = Fisher’s exact test, c = Kendall’s tau-b
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(Table 2). About half the patients in both countries
understood that keeping high blood pressure under con-
trol could prevent heart attacks. About 40–50% of pa-
tients understood that high cholesterol as well as bad
cholesterol could contribute towards developing heart
disease. Only 20% of patients knew about role of good
cholesterol role in minimising heart attack. About half
of the patients were aware that unhealthy diets could
cause high cholesterol. Regarding the link between dia-
betes and heart disease only 47.5% in India and 44.1% in
UK knew this. However, patients in both countries
understood the CVD risk associated with smoking and
the role of quitting smoking. In addition, there were alsoTable 2 CVD risk knowledge in general between India and UK (n =
Overall general CVD risk knowledge score who got it correct for HDFQ-RA1
A person always knows when they have heart disease
A person who smokes is more likely to develop heart disease
Keeping blood pressure under control will reduce a person’s chance of deve
A person with high cholesterol is more likely to develop heart disease
If your ‘good’ cholesterol (HDL) is high you are more likely to develop heart
Only exercising in a gym or in an exercise class will lower a person’s chance
disease
Eating fatty foods does not affect blood cholesterol levels
A person with diabetes is more likely to develop heart disease
Overall general CVD risk knowledge score who got it correct for HDFQ-RA2
If you have a family history of heart disease, you are more likely to develop h
Regular exercise will lower a person’s chance of getting heart disease
A person who stops smoking will lower their chance of developing heart dis
A person with high blood pressure is more likely to develop heart disease
If your ‘bad’ cholesterol (LDL) is high you are more likely to develop heart di
Being overweight increases a person’s chance of developing heart disease
The older a person is, the more likely they are to develop heart disease
Walking and gardening are considered exercise that will help lower a person
heart disease
a = Kendall’s tau-b, b = Fisher’s exact testwell aware about the role of exercise and walking in re-
ducing CVD.
Comparison of RA and CVD risk knowledge between
India and UK
Knowledge regarding RA and CVD was even more lim-
ited (32.8% in India and 34.4% in UK). Almost 40% of
the patients with RA were aware that keeping weight
under control, stopping smoking, keeping blood pressure
and cholesterol under control can reduce the risk of
CVD in patients with RA (Table 3). However, only 15%
new that RA increased risk of developing heart disease
and a quarter of patients knew about increased CVD risk
with anti-inflammatory drugs. Regarding the impact of236)










loping heart disease 56.8% 51.7% 0.514
55.1% 55.9% 1.000
disease 16.1% 24.6% 0.145
of developing heart 34.7% 29.7% 0.486
50.0% 55.1% 0.515
47.5% 44.1% 0.695
57.7% 57.2% 0.886 a
P value
b
eart disease 28.0% 22.9% 0.455
80.5% 77.1% 0.633
ease 70.3% 68.6% 0.888
62.7% 59.3% 0.689
sease 40.7% 40.7% 1.000
73.7% 78.0% 0.543
39.0% 44.9% 0.429
’s chance of developing 66.9% 66.1% 1.000
Table 3 RA and CVD risk knowledge between India and UK (n = 236)





Overall RA related CVD risk knowledge score who got it correct for HDFQ-RA-1 38.1% 40.7% 0.618 a
P value
b
A person with rheumatoid arthritis can reduce their chance of heart disease by keeping their weight under
control
44.1% 51.7% 0.297
A person with rheumatoid arthritis can reduce their chance of heart disease by stopping smoking 41.5% 49.2% 0.296
People with rheumatoid arthritis should not exercise because it can damage their joints 51.7% 50.0% 0.896
Anti-inflammatory medications, such as diclofenac or ibuprofen, taken by patients with rheumatoid arthritis
may increase the chance of heart disease
27.1% 27.1% 1.000
Having lots of inflammation (‘flares’) of rheumatoid arthritis adds to the increased chance of heart disease 26.3% 25.4% 1.000
Overall RA related CVD risk knowledge score who got it correct for HDFQ-RA-2 27.5% 28.0% 0.912 a
P value
b
Patients with rheumatoid arthritis are more likely to develop heart disease 16.1% 13.6% 0.715
Rheumatoid arthritis affects the balance of ‘good’ and ‘bad’ cholesterol in the blood in an undesirable way 19.5% 22.0% 0.748
Long term or high doses of steroid medication taken by a person with rheumatoid arthritis may cause
diabetes.
15.3% 20.3% 0.395
A person with rheumatoid arthritis can reduce their chance of heart disease by keeping their cholesterol
under control
43.2% 39.8% 0.692
A person with rheumatoid arthritis can reduce their chance of heart disease by keeping their blood
pressure under control
43.2% 44.1% 1.000
a = Kendall’s tau-b, b = Fisher’s exact test
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only a quarter knowing about it. About 20% were aware
that steroids increase the risk of diabetes.Comparison of CVD risk knowledge between patients
with and without CVDs
A higher proportion of those with existing CVDs knew
that a person with high cholesterol is more likely to de-
velop heart disease (77% vs 49%, p < 0.001) and that pa-
tients with rheumatoid arthritis are more likely to
develop heart disease (35% vs 9%, p < 0.001). These were
the only significant differences.Table 4 Illness Perception Questionnaire
India UK
Median and inquartile range P value a
Consequences 7 (5–10) 7 (5–10) 0.925
Timeline 9 (5–10) 9 (5–10) 0.838
Personal control 7 (5–9) 7 (4–9) 0.588
Treatment control 10 (8–10) 9 (7–10) 0.301
Identity 7 (5–10) 7 (5–10) 0.767
Concerned 10 (8–10) 10 (8–10) 0.766
Coherence 8 (5–10) 7 (5–10) 0.839
Emotional representation 8 (5–10) 8 (5–10) 0.804
a Mann-WhitneyIllness perception questionnaire
The IPQ domains of consequences, timeline, and per-
sonal control over RA, treatment control, identity, con-
cerns, coherence and emotional representation were
similar between patients in the two countries (Table 4).
However, patients’ belief about the cause of RA was
significantly different between patients from the two
countries. UK patients ranked diet (p = 0.006) over work
(p = 0.007) and infection (p = 0.036) higher than Indian
patients whereas there was no difference in role of gen-
etics and stress. (Table 5).Post hoc power calculation
Based on the observed variability in this study, the sam-
ple size of 118 per group had 80% power at the 5% sig-
nificance level to detect a difference of 10 for general
CVD risk knowledge and 12 for RA specific CVD risk
knowledge.
Discussion
This study evaluated the level of CVD risk knowledge
among patients of South Asian origin with RA in two
different geographical regions. The purpose was to




Number of patients Number of patients
Diet 10 26 0.006*
Genetics 7 6 1.000
Obesity 8 9 1.000
Stress 6 12 0.219
Over work 0 8 0.007*
Infection 1 8 0.036*
* = significant at < 0.05 a Fisher’s exact test
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different rheumatology settings (of well-resourced and
resource constrained) to identify gaps in our under-
standing of CVD risk knowledge in patients of South
Asian origin with RA. The present study highlights three
points: Patients of South Asian origin have limited
knowledge of CVD related issues in general. Further
knowledge about RA related issues impacting CVD risk
was poor and finally no differences were observed be-
tween the level of CVD knowledge among patients from
the two countries.
In this study, the percentage of participants suffering
with diabetes, hypertension, high cholesterol was margin-
ally higher in the UK population as compared to India.
Additionally, UK patients were noted to be taking more
cholesterol and blood pressure medications. This could be
related to better screening and better access to primary
health care in UK. Despite the fact that they were on
medication, their knowledge was still similar to that of In-
dian patients. This could be a reflection on clinicians’ in-
ability to communicate key messages to patients.
Interestingly, a number of studies published in the UK show
higher rates and earlier onset of CVD due to various predis-
position and lifestyle factors in ethnic minorities [9, 11, 23].
Abnormal lipid and especially low-density lipoprotein (LDL)
hold a key role in the atherosclerotic processes which has been
reported to result in premature atherosclerosis [8]. This has
been shown to be elevated in patients of South Asian origin
with RA [8]. Additionally, stress plays an important role in de-
veloping the CVD risk [24]. In this regard, Solomon and col-
leagues observed an association between symptoms of tension
and carotid plaque occurrence in White and Black Africans
RA patients [25]. Furthermore, data suggests that poor adher-
ence to chronic medications may further increase the risk
[25]. The ability to fully engage rests on patients’ perceived
seriousness of the disease. We have previously shown in the
UK this to be linked with patients’ illness and cultural beliefs
[26]. Furthermore, patients’ perceived views on causation dedi-
cate their ability to fully control their symptoms [26]. In our
study, we found patients’ beliefs about the cause of RA rank-
ing were significantly different between the patients from twocountries. People in the UK believed diet, overworking and in-
fection as a cause of RA. Psychological frameworks show that
some patients deter from following treatment advice some-
times these are strongly influenced by their ‘common-sense’
beliefs about their illness and treatment [27] indeed we have
shown these links in our previous work [26]. Therefore, UK
patients may not exercise as they think it will worsen RA. A
recent review highlights that stress, lack of exercise and high
fat diet were considered the major causes of CVD by South
Asians [28].
In India, which has a much higher CVD related death
rate of 272 per 100, 000 as compared to global average
of 235 per 100,000, the knowledge regarding CVD is low
[29]. CVD disease in India occurs at a much younger
age and has higher mortality probably related to lack of
knowledge leading to late recognition of symptoms and
suboptimal health care facilities [29]. In a recent study
investigating the acute myocardial infarction (AMI) and
sudden cardiac arrest in Beijing, Shanghai and Banga-
lore, a baseline assessment of public knowledge, atti-
tudes and practices was performed [30]. That study
reported that the CVD risk knowledge was only modest.
Smoking was identified as risk factor by over 90% while
hypertension and high cholesterol was named as risk
factor by only half and less than quarter knew that dia-
betes and lack of exercise increase the risk of CVD. This
has also been found in our study. Almost one quarter
could not name any symptom which suggested a myo-
cardial infarction while only 60% recognized chest pain
as an important symptom [28]. That survey also sug-
gested that the physicians were not counselling patients
on the CVD risk factors or its symptoms. Moreover, the
co-morbidities were not reported in that study.
Similar studies across the globe also show the know-
ledge gap between the Caucasians and the South Asian
patients as regards CVD risk knowledge [14, 16]. Studies
on patients with CVD and diabetes all highlight the fact
that patients of South Asian origin have significant bar-
riers to acquiring sufficient knowledge and therefore
have low level of knowledge [9, 11]. Patients of South
Asian origin have been found to be concerns about the
long-term management of their underlying illness [11].
Studies further report associations with lack of know-
ledge about the long-term consequences of the illness
and cultural stigma attached to chronic illness [31, 32].
There are only a few studies that assess CVD know-
ledge in patients with RA. John et al. [19] reported that
in UK Caucasians with RA nearly 80% of respondents
were aware of the modifiable risk factors for CVD, in
contrast to only 50% in our study. Similar to our data,
patients in the John et al. study were reported to have
poor knowledge about increase in CVD risk related to
anti-inflammatory drugs and RA flare. This suggests that
rheumatology clinics are not equipped to educate the
Kumar et al. BMC Rheumatology            (2020) 4:57 Page 8 of 9patients about heart disease. Moreover in a study of
South Korean patients reported that RA patients per-
ceive their CVD risk to be less as compared to that cal-
culated using the Framingham risk score. This also
suggests a knowledge gap [33].
Our results pose a challenge and an opportunity in a very
important clinical arena – that is, how to increase the CVD
risk knowledge in patients of South Asian origin. The UK
health services offer more opportunities to screen the CVD
risk and educate patients and implement change. These
range from general lifestyle, diet, physical and exercise [16].
Behavioural change and cultural influences have also been
explored extensively [15]. Interventions such as Khush Dil
[16] have been employed to reduce the risk of CVD in pa-
tients of South Asian origin. We strongly recommend simi-
lar educational programme in the rheumatology clinics are
required that includes behavioural changes towards exer-
cise, quitting smoking, reducing weight, adherence to all
medication including lipid lowering drugs, anti-
hypertensives and DMARDs. In addition, we also need to
communicate with patients about the effective control of
RA disease activity and long-term consequences of flares in
RA and its added risk to developing CVD. Recently in the
UK, leaflets as well as cognitive behavioural programs have
been developed in English to increase an awareness of CVD
risk knowledge among patients with RA [10, 17]. These are
implemented in collaboration with National Rheumatoid
Arthritis Society (NRAS). For patients of South origin with
lower literacy level Apni Jung (our fight against rheuma-
tism) (www.nras.org.uk/apnijung) has been developed as a
platform on the NRAS website. We need to develop pro-
grammes in CVD risk knowledge that are culturally sensi-
tive on the existing platform so that these can be accessed
both in the UK and India.
The study had some limitations. Data on Framingham
Risk Score in these patients from both countries would
have helped us to know the actual risk of CVD and then
we could have studied the relationship between know-
ledge about CVD and risk in an individual. Data on pa-
tients’ understanding of RA could have provided insights
into their knowledge and whether those with poor un-
derstanding of RA also had poor CVD risk knowledge.
Data on medication therapy for RA would have helped
us to know the possible cause of higher disease activity
in the UK patients. Translating questionnaires into dif-
ferent languages is always a challenge we recognise this
as a limitation. In future study the HDFQ-RA 1 and
HDFQ-RA 2 will require a larger group of patients for
validation. This pilot study demonstrates that the use of
HDFQ-RA 1 and HDFQ-RA 2 can be useful to under-
stand the CVD risk knowledge in patients of South
Asian origin living with RA. Due to funding restrictions,
data were collected only from two centres. Despite these
limitations, for the first time, our study suggests thatpeople of South Asian origin have poor CVD risk know-
ledge regardless of whether they are in resource rich or
resource poor settings. Further larger scale study is re-
quired to confirm this.
Conclusion
This novel study highlights CVD risk knowledge in two
different countries. Despite many awareness campaigns
in the UK patients still displayed similar “general” CVD
risk knowledge to patients in India. Poor RA specific
CVD risk knowledge suggests a need to educate ethnic
minorities in developed world as well as all patients in
developing country like India.
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